Compile Data Set for Download or QSAR
maximum 50k data
Found 1180 with your filter
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM50323732(3-(2-amino-1,3-benzothiazol-6-yl)-1-{[2-(4-methylp...)
Affinity DataIC50:  0.5nMAssay Description:Inhibition of p110deltaMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM50323728(2-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1H-pyrazo...)
Affinity DataIC50:  0.700nMAssay Description:Inhibition of p110deltaMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM50323731(CHEMBL1213117 | N-(6-(4-amino-1-((2-(4-methylpiper...)
Affinity DataIC50:  1nMAssay Description:Inhibition of p110deltaMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM25028(4-[2-(1H-indazol-4-yl)-6-[(4-methanesulfonylpipera...)
Affinity DataIC50:  3nMAssay Description:Inhibition of p110deltaMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM25028(4-[2-(1H-indazol-4-yl)-6-[(4-methanesulfonylpipera...)
Affinity DataIC50:  3nMAssay Description:Inhibition of p110alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM50323732(3-(2-amino-1,3-benzothiazol-6-yl)-1-{[2-(4-methylp...)
Affinity DataIC50:  4nMAssay Description:Inhibition of p110gammaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM50315213(2-(difluoromethyl)-1-(4,6-dimorpholin-4-yl-1,3,5-t...)
Affinity DataIC50:  4.60nMAssay Description:Inhibition of p110deltaMore data for this Ligand-Target Pair
LigandPNGBDBM169994(US9073940, 344)
Affinity DataIC50:  6nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM50323730(2-((4-amino-3-(3-hydroxyprop-1-ynyl)-1H-pyrazolo[3...)
Affinity DataIC50:  7nMAssay Description:Inhibition of p110deltaMore data for this Ligand-Target Pair
LigandPNGBDBM170092(US9073940, 450)
Affinity DataIC50:  7nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM109327(US8609666, 47)
Affinity DataIC50:  8nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM109313(US8609666, 33)
Affinity DataIC50:  9nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM50323732(3-(2-amino-1,3-benzothiazol-6-yl)-1-{[2-(4-methylp...)
Affinity DataIC50:  9nMAssay Description:Inhibition of p110betaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM50323729(2-((4-amino-3-(3-fluoro-4-hydroxyphenyl)-1H-pyrazo...)
Affinity DataIC50:  9nMAssay Description:Inhibition of p110deltaMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM109317(US8609666, 37)
Affinity DataIC50:  10nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM110513(US8614215, 85)
Affinity DataIC50:  10nMAssay Description:The assay combines the scintillation proximity assay technology (SPA, Amersham) with the capacity of neomycin (a polycationic antibiotic) to bind pho...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM110459(US8614215, 31)
Affinity DataIC50:  11nMAssay Description:The assay combines the scintillation proximity assay technology (SPA, Amersham) with the capacity of neomycin (a polycationic antibiotic) to bind pho...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM169955(US9073940, 305)
Affinity DataIC50:  11nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM110530(US8614215, 102)
Affinity DataIC50:  12nMAssay Description:The assay combines the scintillation proximity assay technology (SPA, Amersham) with the capacity of neomycin (a polycationic antibiotic) to bind pho...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM109314(US8609666, 34)
Affinity DataIC50:  13nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170116(US9073940, 474)
Affinity DataIC50:  13nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170069(US9073940, 427)
Affinity DataIC50:  13nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170024(US9073940, 376)
Affinity DataIC50:  13nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170114(US9073940, 472)
Affinity DataIC50:  14nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170012(US9073940, 364)
Affinity DataIC50:  14nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM109336(US8609666, 56)
Affinity DataIC50:  15nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170107(US9073940, 465)
Affinity DataIC50:  15nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170030(US9073940, 382)
Affinity DataIC50:  15nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM109341(US8609666, 61)
Affinity DataIC50:  15nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM169956(US9073940, 306 | US9073940, 345)
Affinity DataIC50:  16nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170000(US9073940, 350)
Affinity DataIC50:  16nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM50315213(2-(difluoromethyl)-1-(4,6-dimorpholin-4-yl-1,3,5-t...)
Affinity DataIC50:  16nMAssay Description:Inhibition of p110alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM170064(US9073940, 422)
Affinity DataIC50:  16nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170061(US9073940, 413)
Affinity DataIC50:  16nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170010(US9073940, 362)
Affinity DataIC50:  17nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM110450(US8614215, 22)
Affinity DataIC50:  18nMAssay Description:The assay combines the scintillation proximity assay technology (SPA, Amersham) with the capacity of neomycin (a polycationic antibiotic) to bind pho...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170105(US9073940, 463)
Affinity DataIC50:  18nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170101(US9073940, 459)
Affinity DataIC50:  18nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM109316(US8609666, 36)
Affinity DataIC50:  18nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170032(US9073940, 384)
Affinity DataIC50:  19nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM109294(US8609666, 14)
Affinity DataIC50:  19nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM110451(US8614215, 23)
Affinity DataIC50:  20nMAssay Description:The assay combines the scintillation proximity assay technology (SPA, Amersham) with the capacity of neomycin (a polycationic antibiotic) to bind pho...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM50323729(2-((4-amino-3-(3-fluoro-4-hydroxyphenyl)-1H-pyrazo...)
Affinity DataIC50:  20nMAssay Description:Inhibition of p110gammaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM170096(US9073940, 454)
Affinity DataIC50:  20nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170088(US9073940, 446)
Affinity DataIC50:  20nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM110430(US8614215, 1)
Affinity DataIC50:  21nMAssay Description:The assay combines the scintillation proximity assay technology (SPA, Amersham) with the capacity of neomycin (a polycationic antibiotic) to bind pho...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM110456(US8614215, 28)
Affinity DataIC50:  21nMAssay Description:The assay combines the scintillation proximity assay technology (SPA, Amersham) with the capacity of neomycin (a polycationic antibiotic) to bind pho...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Medical Research Council-Laboratory Of Molecular Biology

Curated by ChEMBL
LigandPNGBDBM50323734(3-((4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidi...)
Affinity DataIC50:  21nMAssay Description:Inhibition of p110deltaMore data for this Ligand-Target Pair
LigandPNGBDBM169952(US9073940, 302)
Affinity DataIC50:  21nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM170102(US9073940, 460)
Affinity DataIC50:  21nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 1180 total ) | Next | Last >>
Jump to: